Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer

Pancreatic cancer is a challenging disease with a low 5-year survival rate. There are areas for improvement in the tools used for screening, diagnosis, prognosis, treatment selection, and assessing treatment response. Liquid biopsy, particularly cell free DNA liquid biopsy, has shown promise as an a...

Descripción completa

Detalles Bibliográficos
Autores principales: Grunvald, Miles W., Jacobson, Richard A., Kuzel, Timothy M., Pappas, Sam G., Masood, Ashiq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589736/
https://www.ncbi.nlm.nih.gov/pubmed/33081107
http://dx.doi.org/10.3390/ijms21207651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589736/
https://www.ncbi.nlm.nih.gov/pubmed/33081107
http://dx.doi.org/10.3390/ijms21207651

Ejemplares similares